Klebsiella pneumoniae accumulates molybdenum during nitrogenase derepression. The molybdenum is primarily in nitrogenase component I in the form of iron-molybdenum cofactor (FeMo-co 
Nitrogenase is composed of two different proteins (4, 25) : nitrogenase component I and nitrogenase component II. In Klebsiella pneumoniae (15) , the two subunits of component I are coded by the genes nifK and nifD which share an operon with the component II gene (nifH) . Component I contains an iron-molybdenum cofactor (FeMo-co) which can be extracted (17) with N-methylformamide (NMF). FeMo-co can activate in vitro nitrogenase from certain Nif-mutants (10, 15, 17) and is believed to be the active site of nitrogen reduction (13, 17, 18) . Very little is known about the pathway of biosynthesis of FeMo-co (22) . Azotobacter vinelandii UW45 was the first mutant shown to lack FeMo-co (10) . In the best-studied nitrogen-fixing organism, K. pneumoniae, several genes have been identified whose products are necessary for the presence of an active cofactor in nitrogenase component I. Mutants with lesions in the genes nifB, nifN, and nijE synthesize a cofactorless nitrogenase component I that can be activated in vitro by the addition of purified FeMo-co (15, 17) . The protein products of these genes have been identified (14, 15, 23) , but there is no information about the processes that they catalyze. Recently, mutants defective in another gene, nifQ, have been characterized as conditional FeMo-co mutants requiring large amounts of molybdate in the medium to suppress the phenotype of the mutation (7) . So far, there has been no evidence for the presence of molybdenum-containing intermediates accumulating in mutants defective in FeMo-co biosynthesis. It seemed reasonable that FeMo-co is synthesized directly on nitrogenase component I. This paper demonstrates that active FeMo-co can be synthesized in the absence of nitrogenase component I and that accumulation of Mo in nitrogenase-derepressed cells requires an intact biosynthetic pathway for FeMo-co. growth of K. pneumoniae. Mo-free K medium was prepared as described previously (7) . A. vinelandii strains were grown on modified Burk medium (24) Bacterial strains. Wild-type K. pneumoniae UN is strain M5al (3). Mutant strains of K. pneumoniae are described in Table 1 . A. vinelandii UW45, lacking active FeMo-co, has been described previously (1, 10, 20) .
Growth and derepression. K. pneumoniae cells were grown and derepressed for nitrogenase as described previously (7), except that for extract complementation experiments, overnight anaerobic cultures in KN medium were derepressed after washing and diluting 1:2 in K medium. A. vinelandii UW45 was derepressed as described previously (20) .
Preparation of crude extracts. Extracts from 99Mo-labeled cals, Piscataway, N.J.) columns (90 by 1 cm) were used for nonaqueous chromatography with NMF-phosphate-dithionite as described previously (17) , and 1-ml fractions were collected.
Other techniques. NMF-phosphate extraction was performed as described previously (17) . Other extractions are described in the text. Anaerobic gel electrophoresis (7), 9Mo labeling (7), scintillation counting (7), and protein assays (2) were performed as described in the references. electrophoresis under nondenaturing conditions gave the results shown in Fig. 1 . In wild-type UN, most of the 99Mo migrated with nitrogenase component I. Considerable label (presumably molybdate) ran into the lower tank or stayed at the top of the gel. Other minor spots (totalling less than 5% of the total counts present in the gel) appeared after prolonged exposure of the film. The FeMo-co-negative mutants (NifB-, NifN-, and NifE-) had most of the label in the form of low-molecular-weight compounds, and no 9Mo could be detected with nitrogenase component I. UN1089 (nifD4409: :Mu) showed no Mo in the area where nitrogenase component I would migrate, in accord with the total absence of the protein in this mutant. However, the radioactivity was distributed in different bands throughout the gel, particularly in a band with lower mobility than nitrogenase component I. This band was not present in the wild-type extracts. The same band appeared faintly in NifB-extracts, but not in extracts from NifN-or NifE-strains.
RESULTS

Molybdenum
The intracellular forms of Mo were also studied by anaerobic gel filtration chromatography of cell extracts labeled with
[99Mo]molybdate. labeled cell extracts from the wild-type and UN1089 strains were subjected to anaerobic extraction with ethanol or NMF (Table 3) in an attempt to find chemical differences between the forms of 99Mo present in both strains. Ethanol precipitated the bulk of the proteins present in the cell extracts. Most of the label present in the wild type was precipitated by ethanol. Strain UN1089 showed an intermediate value between that of the wild type and those of FeMo-co-negative mutants (Table 3) . Most proteins were still soluble in NMF, supernatant and pellet were counted. b Ethanol pellets were extracted with NMF-phosphate as described previously (17) , and supernatants were counted.
C Samples (0.025 ml) were incubated with 9 volumes of NMF in an ice bath for 30 min and centrifuged for 20 min at 9,500 x g, and both supernatant and pellet were counted. but nitrogenase component I showed little solubility in this solvent (data not shown). Twice the amount of Mo was present in NMF precipitates of the wild-type extract when compared with the strain UN1089 extract. The label present in the ethanol precipitates was extracted with NMF plus phosphate under conditions known (17) to release FeMo-co from citric acid-precipitated nitrogenase component I (Table  3) . NMF-phosphate extracts were loaded on an anaerobic Sephadex G-100 column and developed with NMF-phosphate (Fig. 3) . Most of the 99Mo label present in the UN extract eluted in the position described for FeMo-co (17) . In strain UN1089 extracts, a peak appeared that was not present in wild-type extracts. Strain UN1089 extracts also showed a peak eluting in the position of the FeMo-co recovered from the wild-type extracts.
Activation of nitrogenase component I from FeMo-co-negative mutants by extracts of nijD::Mu strains. When extracts from nitrogenase-derepressed cultures of FeMo-co-negative mutants were assayed for nitrogenase by the acetylene reduction technique, very low basal activity was observed (Table 4 ). This activity could be increased to levels of the order of that found in wild-type extracts after incubation with FeMo-co. No activity was detected in extracts from UN1089 (niffJ4409: :Mu), and none was observed after FeMo-co addition (Table 4) . When strain UN1089 extracts were coincubated with extracts of NifB-, NifN-, or NifEmutants, acetylene reduction activity appeared (Table 4) . This activity was much lower than that in wild-type extracts or in extracts reconstituted by the addition of an excess of FeMo-co. However, it was significantly higher than that present in the original extracts. The activity also appeared after incubation of strain UN1089 extracts with extracts of the mutant UW45 from A. vinelandii (Table 4) . Exposure of the UN1089 extracts to oxygen resulted in loss of the ability to generate the activity (data not shown). Since FeMo-co- negative mutants require FeMo-co for activity, strain UN1089 extracts were contributing either FeMo-co (or a precursor) or an enzyme necessary for processing of a precursor present in FeMo-co-negative extracts. The activity of the system was linearly dependent on the amount of strain UN1089 extract added (Table 5) , and the activating factor from UN1089 was still present when crude extracts were obtained in NMF and after several rounds of precipitation with NMF-phosphate (data not shown). That UN1089 extracts provide the Mo source to the system was proven by using tungsten-derepressed cells. No activity was generated by the addition of W extracts to FeMo-co-negative extracts ( Table 6 ). Cultures of UN1089 (niJJD4409::Mu) in which nitrogenase was repressed by the addition of ammonia did not generate activatable extracts (data not shown).
Other mutants with lesions in nitrogenase component I genes could be used in the same system. Strains with point [niJD4697]) also generated acetylene-reducing activity after incubation with FeMo-co-negative mutants (Table 7). DISCUSSION Our previous work (7, 11) showed that Mo does not accumulate in K. pneumoniae under growth conditions which make molybdoenzymes (e.g, nitrogenase) dispensable. Under nitrogen-fixing conditions, wild-type K. pneumoniae scavenges Mo from the medium and accumulates it primarily in nitrogenase component I, which acts as the main reservoir of Mo inside the cell (7) . All the Mo present in nitrogenase component I is in the form of FeMo-co, the ironmolybdenum cofactor specific for nitrogenase (17) . This, together with the fact that no Mo-containing intermediates in the biosynthesis of the cofactor have been identified, supported the idea that FeMo-co is assembled on nitrogenase component I. The idea was further strengthened after consideration of some of the physical properties of FeMo-co, such as its sensitivity to water or oxidizing conditions (17) , which make stability of free FeMo-co inside the cell questionable. These facts prompted us to study the characteristics of Mo accumulation in different FeMo-co-negative mu- This surprising result confirms a previous observation (7) and implies that in the absence of nitrogenase component I, Mo can be stored in forms which are not readily detectable in the wild type, provided that the rest of the genes involved in FeMo-co biosynthesis are intact. We investigated the intracellular forms of Mo in different strains by trying to identify those which form the bulk of the Mo pool in mutant strain UN1089. The results allow an important conclusion with respect to the state of Mo in FeMo-co-negative (NifB-, NifN-, and NifE-) mutants: of the small Mo pool, no detectable amounts were present in nitrogenase component I. This can be interpreted in two different ways with respect to the possible function of the products of these genes: either they are involved in the transfer of FeMo-co to nitrogenase component I, or they are involved in the biosynthesis of the cofactor, and the intermediate forms become unstable and are destroyed when the pathway cannot proceed to the finished product. The result obtained with the NifB-mutant deserves further comment in view of the results obtained by others (6) . These investigators purified nitrogenase component I from two different NifB-mutants to a maximum degree of purity of 90% and reported the presence of a variable amount of Mo in their preparations, accounting for 0.4 to 0.9 mol/mol of nitrogenase component I. These results are in direct conflict with ours, which indicate essentially no Mo in nitrogenase component I of NifB-strains. Our electrophoresis technique requires minor manipulation, but in view of the reported lability of nitrogenase component I from NifB-mutants (6) , it may still be too harsh. However, the analysis of nonexchangeable Mo pools in whole cells of UN1655 (nifB4691) ( Table 2 ) and nine other NifB-strains with point mutations located in five different nifB deletion groups (data not shown) gave total intracellular Mo values too low to allow for the published values (6) . Mutants with lesions in other FeMo-co genes (nifN and nifE) also showed very low intracellular Mo pools. Purified preparations of nitrogenase component I from NifB-mutants show little activatability by FeMo-co (6), whereas crude cell extracts of NifB-mutants are activatable to levels of at least 85% of the wild-type activity (our unpublished data). In contrast, purified nitrogenase component I of strain UW45, a FeMo-co-negative A. vinelandii mutant, showed no Mo and high activatability (5) . UN1089 (nifD4409::Mu) showed a characteristic distribution of Mo species in the electropherograms with an increase in some minor bands running faster than nitrogenase component I and the appearance of a major band with lower mobility than nitrogenase component I. This band was a candidate for an intermediate in the synthesis or processing of FeMo-co that would accumulate only when the final acceptor, nitrogenase component I, was missing. Gel filtration chromatography showed that this band has a molecular weight of ca. 50,000. This high-molecular-weight Mo-containing compound is probably a protein. All the Mo species identified were sensitive to oxygen or denaturing agents such as sodium dodecyl sulfate or urea, which transformed them into low-molecular-weight compounds, indistinguishable from molybdate both by electrophoresis and gel chromatography.
The presence, in strain UN1089, of Mo species which are not usually found in the wild type was shown by their different behavior with respect to organic solvents. Extracts from the FeMo-co-negative mutants had a higher proportion of protein-independent Mo as judged by the amount of 99Mo remaining in the ethanol supernatants after precipitation of the protein fraction. The component I-negative mutant showed an intermediate level, whereas most of the Mo was protein bound in wild-type extracts. NMF precipitated twice as much Mo in the wild-type extract as in the strain UN1089 extract, a reflection of the insolubility of nitrogenase component I in NMF. FeMo-co is quantitatively extracted from citric acid-phosphate precipitates of purified nitrogenase component I by NMF-phosphate (17) . The acid treatment is required to unfold the protein and make FeMo-co accessible to the solvent. Thus, ethanol precipitates of purified nitrogenase component I gave low-yield FeMo-co preparations (data not shown), but the cofactor was still extracted. Extraction of the ethanol precipitates from crude cell extracts of the wild-type and UN1089 strains showed differences between them, with Mo forms in the wild type being more extractable. Gel filtration chromatography under anaerobic, nonaqueous conditions was used (17) to further purify FeMo-co and to separate (12) FeMo-co from Mo-co (the molybdenum cofactor in nitrate reductase). NMF-phosphate extracts of strain UN separated by this technique gave a major 99Mo peak with the same mobility as purified FeMoco. A new peak with lower retention time appeared in strain UN1089 extracts. Since this was the main "Mo-containing fraction, it is feasible to think that it corresponds to the Mocontaining part of the major Mo-containing protein identifiable by polyacrylatnide gel electrophoresis and by gel chromatography of cell extracts. UN1089 extracts also showed a 99Mo peak with a mobility similar to that of FeMo-co extracted from purified nitrogenase component I or obtained from 99Mo-labeled wild-type cell extracts.
The possibility that the Mo-containing, NMF-phosphateextractable compound present in strain UN1089 extracts which showed the same mobility as FeMo-co was indeed FeMo-co was tested functionally by complementation with extracts from well-characterized FeMo-co-negative mutants. Coincubation of the extract of a nifD::Mu strain with an extract from a mutant with a lesion in any of the known FeMo-co genes resulted in generation of acetylene-reducing activity. This activity was due to activation of nitrogenase component I in the FeMo-co-negative mutant by strain UN1089 extract. The activity values obtained range from 4 to 36 times above background, which makes them significant; although they are far below the saturation level of the FeMo-co-less nitrogenase component I present in the FeMoco-deficient mutants, as determined by the addition of an excess of purified FeMo-co. It is unlikely that the extract from strain UN1089 contributes an enzyme activity that, in turn, generates FeMo-co from a precursor in view of the linear dependence of activity on the amount of extract added, and especially because the activating factor is still present after the proteins have been denatured by treatment with NMF. It is interesting to note that strain UN1089 extracts could also activate extracts from A. vinelandii UW45, a FeMo-co-negative mutant. FeMo-co was also donated by extracts of mutants with point mutations in any of the two genes, nifK and nifD, coding for subunits of nitrogenase component I; although in this case, the structural proteins are still present and no synthesis of FeMo-co in the absence of nitrogenase component I has to be postulated. It is possible that when nitrogenase component I is altered, the cofactor is loosely bound, allowing donation to an intact FeMo-co-less nitrogenase component I, or that this FeMoco could have the same origin as the FeMo-co present in UN1089 (nifD4409::Mu).
The observations reported in this paper will help further studies on the pathway of biosynthesis of FeMo-co. Mutations in the known FeMo-co genes nifB, nifN, and niJE result in absence of Mo from nitrogenase component I and in impaired capacity to accumulate Mo inside the cells. Thus, these mutants cannot be used to study postulated Mocontaining intermediates in the biosynthesis of the cofactor, presumably because the intermediates are unstable, and they would have to be looked for in kinetic studies of nitrogenase derepression in wild-type strains. In the absence of nittogenase component I, the cofactor is present in a protein bound form. It is likely that this protein is coded by one or more of the FeMo-co genes.
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